KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Shares Outstanding (2016 - 2025)

Acadia Pharmaceuticals has reported Shares Outstanding over the past 16 years, most recently at $170.3 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $170.3 million for Q4 2025, up 2.16% from a year ago — trailing twelve months through Dec 2025 was $170.3 million (up 2.16% YoY), and the annual figure for FY2025 was $170.3 million, up 2.16%.
  • Shares Outstanding for Q4 2025 was $170.3 million at Acadia Pharmaceuticals, up from $169.1 million in the prior quarter.
  • Over the last five years, Shares Outstanding for ACAD hit a ceiling of $170.3 million in Q4 2025 and a floor of $160.2 million in Q1 2021.
  • Median Shares Outstanding over the past 5 years was $163.7 million (2023), compared with a mean of $164.2 million.
  • Biggest five-year swings in Shares Outstanding: increased 3.04% in 2021 and later rose 0.62% in 2023.
  • Acadia Pharmaceuticals' Shares Outstanding stood at $161.0 million in 2021, then increased by 0.65% to $162.1 million in 2022, then increased by 1.6% to $164.7 million in 2023, then increased by 1.25% to $166.7 million in 2024, then grew by 2.16% to $170.3 million in 2025.
  • The last three reported values for Shares Outstanding were $170.3 million (Q4 2025), $169.1 million (Q3 2025), and $168.6 million (Q2 2025) per Business Quant data.